World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
17507
World Ranking
2233
National Ranking
1079

Rick L. Tarleton publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rick L. Tarleton sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 184 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rick L. Tarleton D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rick L. Tarleton sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2020 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Rick L. Tarleton is affiliated with the University of Georgia in the United States and focuses primarily on the field of Medicine, with a significant concentration on Epidemiology, Public Health, Environmental and Occupational Health, Parasitology, Infectious Diseases, and Organic Chemistry.

The main topics of their research include Trypanosoma species research and implications, research on Leishmaniasis studies, synthesis and biological evaluation, parasitic infections and diagnostics, insect symbiosis and bacterial influences, parasites and host interactions, and immune cell function and interaction.

Their research has been published in various venues, with frequent publications in bioRxiv (Cold Spring Harbor Laboratory), The Journal of Immunology, PLoS neglected tropical diseases, Antimicrobial Agents and Chemotherapy, and eLife.

Recent papers authored or co-authored by Rick L. Tarleton include:

  • Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease, 2021, PLoS Pathogens
  • Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates, 2022, Nature Microbiology
  • A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease, 2020, Science Translational Medicine
  • New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up, 2020, Antimicrobial Agents and Chemotherapy
  • High variation in immune responses and parasite phenotypes in naturally acquired Trypanosoma cruzi infection in a captive non-human primate breeding colony in Texas, USA, 2021, PLoS neglected tropical diseases

The scientist collaborates frequently with a set of co-authors, including Sarah A. Hamer, Brooke E. White, Ashley B. Saunders, Ángel M. Padilla, and Susana A. Laucella.

Rick L. Tarleton has received recognition from professional organizations, notably being named a Fellow of the American Association for the Advancement of Science (AAAS) in 2020.

Best Publications

  • Kinetoplastids: related protozoan pathogens, different diseases

    Ken Stuart;Reto Brun;Simon Croft;Alan Fairlamb

  • Susceptibility of β2-microglobulin-deficient mice to Trypanosoma cruzi infection

    R. L. Tarleton;Beverly H Koller;A. Latour;M. Postan

  • Parasite persistence in the aetiology of Chagas disease.

    Rick L. Tarleton

  • Parasite Persistence Correlates with Disease Severity and Localization in Chronic Chagas' Disease

    L. Zhang;R. L. Tarleton

  • Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR

    Kara L. Cummings;Rick L. Tarleton

  • Chagas Disease Etiology: Autoimmunity or Parasite Persistence?

    R.L Tarleton;L Zhang

  • Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.

    R L Tarleton

  • The challenges of Chagas Disease-- grim outlook or glimmer of hope.

    Rick L Tarleton;Richard Reithinger;Julio A Urbina;Uriel Kitron

  • CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes

    Diana L Martin;D. Brent Weatherly;Susana A Laucella;Melissa A Cabinian

  • Immune system recognition of Trypanosoma cruzi.

    Rick L. Tarleton

  • Frequency of Interferon-γ-Producing T Cells Specific for Trypanosoma cruzi Inversely Correlates with Disease Severity in Chronic Human Chagas Disease

    Susana A. Laucella;Miriam Postan;Diana Martin;Bolyn Hubby Fralish

  • Chagas disease: a role for autoimmunity?

    Rick L. Tarleton

  • Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

    Juan M Bustamante;Lisa M Bixby;Rick L Tarleton

  • Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease.

    R. L. Tarleton;Jiaren Sun;L. Zhang;M. Postan

  • Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease

    Rick L. Tarleton;Michael J. Grusby;Miriam Postan;Laurie H. Glimcher

  • The relative contribution of antibody production and CD8 ˛ T cell function to immune control of Trypanosoma cruzi

    Sudesh Kumar;Rick L Tarleton

  • Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.

    Diana Martin;Rick Tarleton

  • Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients.

    María Cecilia Albareda;Susana Adriana Laucella;María Gabriela Alvarez;Alejandro Hector Armenti

  • "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue.

    R. L. Tarleton;L. Zhang;M. O. Downs

  • Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.

    B Wizel;M Nunes;R L Tarleton

  • In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds.

    Adriana M. C. Canavaci;Juan M. Bustamante;Angel M. Padilla;Cecilia M. Perez Brandan

Frequent Co-Authors

Amit P. Sheth
Amit P. Sheth University of South Carolina
Ron Orlando
Ron Orlando University of Georgia
Ricardo E. Gürtler
Ricardo E. Gürtler University of Buenos Aires
Jessica C. Kissinger
Jessica C. Kissinger University of Georgia
Julio A. Urbina
Julio A. Urbina Instituto Venezolano de Investigaciones Científicas
Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Michael J. Grusby
Michael J. Grusby Harvard University
Kenneth Stuart
Kenneth Stuart University of Washington
Peter J. Myler
Peter J. Myler Seattle Children's Hospital
Mariano J. Levin
Mariano J. Levin University of Buenos Aires

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Immunology, branching into healthcare roles can offer dynamic career opportunities. Many professionals enhance their expertise by enrolling in specialized nursing programs, such as online Psychiatric Mental Health Nurse Practitioner (PMHNP) degrees. These programs often come with excellent clinical training options, highlighted by programs with online pmhnp programs with clinical placement that help bridge theory and practical patient care.

Cost remains a key consideration when selecting a degree path. Prospective students can explore the most budget-friendly options thanks to resources detailing the cheapest online pmhnp programs. Affordable programs make advanced degrees more accessible without compromising on quality.

Career advancement is another motivating factor. Nurse practitioners holding a Doctor of Nursing Practice (DNP) degree can expect competitive salaries, which vary by state. Detailed insights into the dnp salary help students plan for their professional future and maximize their return on investment.

Those wishing to broaden their expertise can consider transitioning between specialties. For example, nurses with a Family Nurse Practitioner (FNP) background can advance through an fnp to acnp bridge program online, which offers a flexible path to becoming an Acute Care Nurse Practitioner. Such pathways supplement Immunology knowledge with direct patient care skills in critical settings.

Best Scientists Citing Rick L. Tarleton

Trending Scientists

Recently Published Articles